RNS Number:2459J
EiRx Therapeutics PLC
05 December 2007



                     EIRX THERAPEUTICS PLC ("the Company")

                           Result of general meeting

At the general meeting of the Company held earlier today, all resolutions were
passed.

Application has been made for the re-admission of the Company's ordinary shares
to trading on AIM as Ordinary Shares of 0.001p with trading under the new
designation expected to commence on 6 December 2007.

With effect from re-admission the Company will have 2,975,743,260 Ordinary
Shares of 0.0001p each in issue.



For further information, please contact:

EiRx Therapeutics plc                                        +353 (0)21 432 0847
Colin Telfer PhD, Chief Executive Officer
Grant Thornton Corporate Finance                             +44 (0)20 7383 5100
Philip Secrett / Colin Aaronson


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END
ROMXELFBDLBBFBZ
Eirx Therapeutics (LSE:ERX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Eirx Therapeutics.
Eirx Therapeutics (LSE:ERX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Eirx Therapeutics.